These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11411190)

  • 41. [Hepatic tolerance of atypical antipsychotic drugs].
    Dumortier G; Cabaret W; Stamatiadis L; Saba G; Benadhira R; Rocamora JF; Aubriot-Delmas B; Glikman J; Januel D
    Encephale; 2002; 28(6 Pt 1):542-51. PubMed ID: 12506267
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inferior frontal white matter volume and suicidality in schizophrenia.
    Rüsch N; Spoletini I; Wilke M; Martinotti G; Bria P; Trequattrini A; Bonaviri G; Caltagirone C; Spalletta G
    Psychiatry Res; 2008 Dec; 164(3):206-14. PubMed ID: 19008082
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia.
    Keck PE; Strakowski SM; McElroy SL
    J Clin Psychiatry; 2000; 61 Suppl 3():4-9. PubMed ID: 10724127
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Significant relationship between lifetime alcohol use disorders and suicide attempts in an Australian schizophrenia sample.
    McLean D; Gladman B; Mowry B
    Aust N Z J Psychiatry; 2012 Feb; 46(2):132-40. PubMed ID: 22311529
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk of non-fatal suicide ideation and behaviour in recent onset schizophrenia--the influence of clinical, social, self-esteem and demographic factors.
    Tarrier N; Barrowclough C; Andrews B; Gregg L
    Soc Psychiatry Psychiatr Epidemiol; 2004 Nov; 39(11):927-37. PubMed ID: 15549247
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Maximizing response to first-line antipsychotics in schizophrenia: a review focused on finding from meta-analysis.
    Smith RC; Leucht S; Davis JM
    Psychopharmacology (Berl); 2019 Feb; 236(2):545-559. PubMed ID: 30506237
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factors associated with suicide attempts among patients with schizophrenia.
    Gupta S; Black DW; Arndt S; Hubbard WC; Andreasen NC
    Psychiatr Serv; 1998 Oct; 49(10):1353-5. PubMed ID: 9779911
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is clozapine antisuicidal?
    Kerwin RW; Bolonna AA
    Expert Rev Neurother; 2004 Mar; 4(2):187-90. PubMed ID: 15853559
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypovitaminosis D is associated with negative symptoms, suicide risk, agoraphobia, impaired functional remission, and antidepressant consumption in schizophrenia.
    Fond G; Faugere M; Faget-Agius C; Cermolacce M; Richieri R; Boyer L; Lançon C
    Eur Arch Psychiatry Clin Neurosci; 2019 Dec; 269(8):879-886. PubMed ID: 30078128
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Suicidal behavior in schizophrenia and depression: a comparison.
    Baca-Garcia E; Perez-Rodriguez MM; Diaz Sastre C; Saiz-Ruiz J; de Leon J
    Schizophr Res; 2005 Jun; 75(1):77-81. PubMed ID: 15820326
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of suicide attempts in schizophrenia and major depressive disorder: an exploratory study.
    Banwari GH; Vankar GK; Parikh MN
    Asia Pac Psychiatry; 2013 Dec; 5(4):309-15. PubMed ID: 23857824
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An 18-month longitudinal study of suicidality in patients diagnosed with schizophrenia.
    Buchanan A; Sint K; Stefanovics E; Rosenheck R
    Schizophr Res; 2020 Oct; 224():102-107. PubMed ID: 33046335
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Emotional processing in schizophrenia.
    Kohler CG; Martin EA
    Cogn Neuropsychiatry; 2006 May; 11(3):250-71. PubMed ID: 17354071
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Family interventions and prevention of suicide in first-episode schizophrenia.
    Sher L; Kahn RS
    Acta Psychiatr Scand; 2019 May; 139(5):484. PubMed ID: 30839096
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevention of suicide by clozapine in mental disorders: systematic review.
    Masdrakis VG; Baldwin DS
    Eur Neuropsychopharmacol; 2023 Apr; 69():4-23. PubMed ID: 36640481
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia.
    Meltzer HY; McGurk SR
    Schizophr Bull; 1999; 25(2):233-55. PubMed ID: 10416729
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association between psychopathology and suicidal behavior in schizophrenia. A cross-sectional study of 509 participants.
    Jovanović N; Podlesek A; Medved V; Grubišin J; Mihaljevic-Peleš A; Goran T; Lovretić V
    Crisis; 2013 Jan; 34(6):374-81. PubMed ID: 23942386
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Do antipsychotic drugs influence suicidal behavior in schizophrenia?
    Aguilar EJ; Siris SG
    Psychopharmacol Bull; 2007; 40(3):128-42. PubMed ID: 18007574
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antidepressant drug therapy and suicide in severely depressed children and adults: A case-control study.
    Olfson M; Marcus SC; Shaffer D
    Arch Gen Psychiatry; 2006 Aug; 63(8):865-72. PubMed ID: 16894062
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
    István S; Agoston T; Tamás T; Zoltán J
    Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.